2,230
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Radiation-induced G2/M arrest rarely occurred in glioblastoma stem-like cells

, , , , , , , , & show all
Pages 394-402 | Received 25 Aug 2017, Accepted 02 Feb 2018, Published online: 27 Feb 2018

References

  • Abbas T, Dutta A. 2009. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 9:400–414.
  • Ahmed SU, Carruthers R, Gilmour L, Yildirim S, Watts C, Chalmers AJ. 2015. Selective inhibition of parallel DNA damage response pathways optimizes radiosensitization of glioblastoma stem-like cells. Cancer Res. 75:4416–4428.
  • Balvers RK, Lamfers MLM, Kloezeman JJ, Kleijn A, Pont LMEB, Dirven CMF, Leenstra S. 2015. ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells. J Transl Med. 13:74.
  • Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. 2006. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 444:756–760.
  • Bassoy EY, Chiusolo V, Jacquemin G, Riccadonna C, Walker PR, Martinvalet D. 2016. Glioma stemlike cells enhance the killing of glioma differentiated cells by cytotoxic lymphocytes. PLoS One. 11:e0153433.
  • Berger R, Jennewein C, Marschall V, Karl S, Cristofanon S, Wagner L, Vellanki SH, Hehlgans S, Rodel F, Debatin KM, et al. 2011. NF-κB is required for Smac mimetic-mediated sensitization of glioblastoma cells for γ-irradiation-induced apoptosis. Mol Cancer Ther. 10:1867–1875.
  • Binello E, Germano IM. 2011. Targeting glioma stem cells: a novel framework for brain tumors. Cancer Sci. 102:1958–1966.
  • Bo S, Hui H, Li W, Hui L, Hong X, Lin D, Dai WX, Wu YH, Ai XH, Hao J, et al. 2014. Chk1, but not Chk2, is responsible for G2/M phase arrest induced by diallyl disulfide in human gastric cancer BGC823 cells. Food Chem Toxicol. 68:61–70.
  • Boutros R, Lobjois V, Ducommun B. 2007. CDC25 phosphatases in cancer cells: key players? Good targets? Nat Rev Cancer. 7:495–507.
  • Bucher N, Britten CD. 2008. G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer. Br J Cancer. 98:523–528. *eng.
  • Dai Y, Grant S. 2010. New insights into checkpoint kinase 1 in the DNA damage response signaling network. Clin Cancer Res. 16:376–383.
  • De Souza CP, Ellem KA, Gabrielli BG. 2000. Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events. Exp Cell Res. 257:11–21.
  • Fidoamore A, Cristiano L, Antonosante A, d'Angelo M, Di Giacomo E, Astarita C, Giordano A, Ippoliti R, Benedetti E, Cimini A. 2016. Glioblastoma stem cells microenvironment: the paracrine roles of the Niche in drug and radioresistance. Stem Cells Int. 2016:6809105.
  • Hermann PC, Bhaskar S, Cioffi M, Heeschen C. 2010. Cancer stem cells in solid tumors. Semin Cancer Biol. 20:77–84.
  • Hutchins JR, Clarke PR. 2004. Many fingers on the mitotic trigger: post-translational regulation of the Cdc25C phosphatase. Cell Cycle. 3:41–45.
  • Iacopino F, Angelucci C, Piacentini R, Biamonte F, Mangiola A, Maira G, Grassi C, Sica G. 2014. Isolation of cancer stem cells from three human glioblastoma cell lines: characterization of two selected clones. PLoS One. 9:e105166.
  • Krueger SA, Wilson GD, Piasentin E, Joiner MC, Marples B. 2010. The effects of G2-phase enrichment and checkpoint abrogation on low-dose hyper-radiosensitivity. Int J Radiat Oncol Biol Phys. 77:1509–1517.
  • Li J, Yang CX, Mei ZJ, Chen J, Zhang SM, Sun SX, Zhou FX, Zhou YF, Xie CH. 2013. Involvement of cdc25c in cell cycle alteration of a radioresistant lung cancer cell line established with fractionated ionizing radiation. Asian Pac J Cancer Prev. 14:5725–5730.
  • Lomonaco SL, Finniss S, Xiang C, Decarvalho A, Umansky F, Kalkanis SN, Mikkelsen T, Brodie C. 2009. The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. Int J Cancer. 125:717–722.
  • Lossaint G, Besnard E, Fisher D, Piette J, Dulic V. 2011. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional. Oncogene. 30:4261–4274.
  • Magee JA, Piskounova E, Morrison SJ. 2012. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell. 21:283–296.
  • Nahar K, Goto T, Kaida A, Deguchi S, Miura M. 2014. Effects of Chk1 inhibition on the temporal duration of radiation-induced G2 arrest in HeLa cells. J Radiat Res. 55:1021–1027.
  • Osswald M, Jung E, Sahm F, Solecki G, Venkataramani V, Blaes J, Weil S, Horstmann H, Wiestler B, Syed M, et al. 2015. Brain tumour cells interconnect to a functional and resistant network. Nature. 528:93–98.
  • Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL, et al. 2014. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 344:1396–1401.
  • Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H. 1997. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science. 277:1501–1505.
  • Perdiguero E, Nebreda AR. 2004. Regulation of Cdc25C activity during the meiotic G2/M transition. Cell Cycle. 3:733–737.
  • Rycaj K, Tang DG. 2014. Cancer stem cells and radioresistance. Int J Radiat Biol. 90:615–621.
  • Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. 2004. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem. 73:39–85.
  • Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. 2004. Identification of human brain tumour initiating cells. Nature. 432:396–401.
  • Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJB, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, et al. 2009. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 10:459–466.
  • Tabu K, Muramatsu N, Mangani C, Wu M, Zhang R, Kimura T, Terashima K, Bizen N, Kimura R, Wang W, et al. 2016. A synthetic polymer scaffold reveals the self-maintenance strategies of rat glioma stem cells by organization of the advantageous Niche. Stem Cells. 34:1151–1162.
  • Uto K, Inoue D, Shimuta K, Nakajo N, Sagata N. 2004. Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism. EBBO J. 23:3386–3396.
  • Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR, Rich JN, Sullenger BA. 2010. Notch promotes radioresistance of glioma stem cells. Stem Cells. 28:17–28.
  • Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace AJ Jr, Harris CC. 1999. GADD45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci USA. 96:3706–3711.
  • Wen PY, Kesari S. 2008. Malignant gliomas in adults. N Engl J Med. 359:492–507.
  • Wu J, Lai GZ, Wan F, Xiao ZZ, Zeng LC, Wang XW, Ye F, Lei T. 2012. Knockdown of checkpoint kinase 1 is associated with the increased radiosensitivity of glioblastoma stem-like cells. Tohoku J Exp Med. 226:267–274.
  • Xue J, Zong Y, Li PD, Wang LX, Li YQ, Niu YF. 2016. Low-dose hyper-radiosensitivity in human hepatocellular HepG2 cells is associated with Cdc25C-mediated G2/M cell cycle checkpoint control. Int J Radiat Biol. 92:543–547.
  • Zhao YX, Cui YS, Han J, Ren JH, Wu G, Cheng J. 2012. Cell division cycle 25 homolog c effects on low-dose hyper-radiosensitivity and induced radioresistance at elevated dosage in A549 cells. J Radiat Res. 53:686–694.